GoodRx Holdings, Inc. (GDRX)

3.63 0.13 (3.86%)

As of 2026-11-02 13:19:30 EST

GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.

Traded asNasdaq: GDRX
ISINUS38246G1085
CIK0001809519
LEI529900ATKYECI45EHV09
EIN475104396
Sector—
IndustryServices-Computer Processing & Data Preparation
CEOWendy Barnes
Employees738
Fiscal Year End1231
Address2701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404
Phone(855) 268-2822
Websitehttp://goodrx.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
GDRXGoodRx Holdings, Inc.2026-11-02 13:19:303.630.133.86
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
GDRX0001809519GoodRx Holdings, Inc.US38246G1085529900ATKYECI45EHV09475104396Nasdaq7374Services-Computer Processing & Data Preparation1231DE2701 OLYMPIC BOULEVARDSANTA MONICACA90404UNITED STATESUS(855) 268-28222701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 904042701 OLYMPIC BOULEVARD, SANTA MONICA, CA, 90404——2011Wendy Barnes738http://goodrx.com423,200,000——GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.2026-10-30 03:23:29
This is a preview of the latest data. Subscribe to access the full data.
GDRX Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
GDRX Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2025423,200,000-223,100,000-34.5196———
2024646,300,000222,400,00052.4652———
2023423,900,000-48,200,000-10.2097———
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Romin NabieyChief Financial Officer, Chief Accounting Officer2025347,250102,918379,71834,72217,0611,256,668
Scott WagnerChief Executive Officer202542,7880758,886055,106856,780
Wendy BarnesChief Executive Officer, President2025825,0002,550,00010,921,182071,30123,367,483
Christopher McginnisTreasurer, Chief Financial Officer2025454,8081,250,0003,474,923019,1888,698,916
Karsten VoermannChief Financial Officer202522,2120006,239280,256
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025697
2024738
2023694
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue796,853,000792,324,000750,265,000
Cost Of Revenue57,597,00048,215,00066,925,000
Gross Profit739,256,000744,109,000683,340,000
Research And Development Expenses121,026,000123,749,000135,836,000
General And Administrative Expenses113,960,000117,862,000125,515,000
Operating Expenses709,361,000726,478,000777,272,000
Operating Income87,492,00065,846,000-27,007,000
Net Income30,439,00016,390,000-8,868,000
Earnings Per Share Basic0.090.04-0.02
Earnings Per Share Diluted0.090.04-0.02
Weighted Average Shares Outstanding Basic356,327,000385,737,000410,315,000
Weighted Average Shares Outstanding Diluted356,973,000392,172,000410,315,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents261,820,000448,346,000672,296,000
Marketable Securities Current———
Accounts Receivable235,746,000145,934,000143,608,000
Inventories———
Non Trade Receivables7,223,00003,537,000
Other Assets Current47,205,00064,975,00056,886,000
Total Assets Current643,102,000659,255,000872,790,000
Marketable Securities Non Current———
Property Plant And Equipment12,268,00012,664,00015,932,000
Other Assets Non Current29,095,00023,520,00037,775,000
Total Assets Non Current760,956,000728,812,000716,010,000
Total Assets1,404,058,0001,388,067,0001,588,800,000
Accounts Payable19,405,00014,137,00036,266,000
Deferred Revenue6,705,0006,036,0007,105,000
Short Term Debt5,000,0005,000,0008,787,000
Other Liabilities Current01,457,000—
Total Liabilities Current246,002,000123,903,000122,559,000
Long Term Debt495,000,000500,000,000647,703,000
Other Liabilities Non Current8,741,0006,755,0008,177,000
Total Liabilities Non Current541,794,000539,506,000704,283,000
Total Liabilities787,796,000663,409,000826,842,000
Common Stock34,00038,00040,000
Retained Earnings-1,410,574,000-1,441,013,000-1,457,403,000
Accumulated Other Comprehensive Income———
Total Shareholders Equity616,262,000724,658,000761,958,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization85,218,00069,538,000107,668,000
Share Based Compensation Expense76,626,00099,026,000104,820,000
Other Non Cash Income Expense00-1,348,000
Change In Accounts Receivable88,016,0002,326,00026,467,000
Change In Inventories———
Change In Non Trade Receivables———
Change In Other Assets8,387,000-6,327,00032,162,000
Change In Accounts Payable4,103,000-21,241,00017,456,000
Change In Other Liabilities1,986,000-1,422,000914,000
Cash From Operating Activities167,904,000183,892,000138,292,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment3,521,0001,240,0001,043,000
Acquisition Of Business43,440,00000
Other Investing Activities2,500,000——
Cash From Investing Activities-119,960,000-70,347,000-55,766,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock1,308,0001,766,0001,390,000
Repurchase Of Common Stock216,372,000159,704,000103,974,000
Issuance Of Long Term Debt0472,033,000—
Repayment Of Long Term Debt5,000,000639,038,0005,271,000
Other Financing Activities———
Cash From Financing Activities-234,470,000-337,495,000-167,395,000
Change In Cash-186,526,000-223,950,000-84,869,000
Cash At End Of Period261,820,000448,346,000672,296,000
Income Taxes Paid13,127,00023,623,00017,243,000
Interest Paid40,837,00055,099,00048,799,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share0.090.04-0.02
Price To Earnings Ratio30.1111116.25-335
Earnings Growth Rate125-300-75
Price Earnings To Growth Ratio0.2409-0.38754.4667
Book Value Per Share1.72951.87861.857
Price To Book Ratio1.56692.47523.608
Ebitda171,389,000162,473,000172,771,000
Enterprise Value1,203,826,1701,850,331,0502,733,304,500
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.81130.69690.8616
Capital Expenditures84,822,00066,270,000103,780,000
Free Cash Flow83,082,000117,622,00034,512,000
Return On Equity0.04940.0226-0.0116
One Year Beta1.24050.82141.9785
Three Year Beta1.3391.93162.0121
Five Year Beta1.69091.8051.9504
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Hirsch Douglas JosephDirector2026-10-2620,521A341,457
Hirsch Douglas JosephDirector2026-10-2620,521D20,521
Barnes Wendy LynnDirector2026-10-15115,149A856,806
Barnes Wendy LynnDirector2026-10-1550,021D806,785
Barnes Wendy LynnDirector2026-10-1551,177A857,962
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Anthony E. Gonzalez2021-04-23OH16Purchase2021-03-25—$100,001 - $250,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Golden State Wealth Management, LLC2026-09-30165503.3
MACKENZIE FINANCIAL CORP2026-09-301,345,390408,9333.29
Creative Planning2026-09-3092,82428,2143.29
Covestor Ltd2026-09-308,0002,5203.1746
Prescott Group Capital Management, L.L.C.2026-09-306,927,1022,105,5023.29
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
AMERICAN CENTURY ETF TRUST2026-08-31Avantis U.S. Small Cap Equity ETFAVSC134,514469,453.860.0151
AMERICAN CENTURY ETF TRUST2026-08-31Institutional ClassAVSCX9373,270.130.0021
AMERICAN CENTURY ETF TRUST2026-08-31G ClassAVSBX9373,270.130.0021
VANGUARD WORLD FUND2026-08-31ETF SharesVHT282,589986,235.610.0045
VANGUARD WORLD FUND2026-08-31Admiral SharesVHCIX282,589986,235.610.0045
This is a preview of the latest data. Subscribe to access the full data.